DXC Technology Company (DXC) SEC Filings & Earnings Calls
EquiReason read 13 DXC Technology Company SEC filings in the last 12 months. Latest: 10-Q on 2026-07-31 — DXC reported Q1 FY2027 results with revenue decline and margin compression, but a large litigation gain boosted EPS..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
31 Jul 202610-QDXC reported Q1 FY2027 results with revenue decline and margin compression, but a large litigation gain boosted EPS.earningsopen
Figures in the filing · each found in the filing text
| Gross margin · Q1-2027 | 20.4% | |
| Adjusted EBIT · Q1-2027 | $150M | -31% y/y |
| Non-GAAP EPS (diluted) · Q1-2027 | $0.40 | -41% y/y |
| GAAP diluted EPS · Q1-2027 | $0.73 | +711% y/y |
| Net cash provided by operating activities · Q1-2027 | $418M | +125% y/y |
| Total debt · 2026-06-30 | $3.50B | |
| Cash and cash equivalents · 2026-06-30 | $1.96B | |
| Organic revenue growth · Q1-2027 | -6.7% | |
| CES organic revenue growth · CES · Q1-2027 | -3.0% | |
| GIS organic revenue growth · GIS · Q1-2027 | -11.1% |
Risks flagged
Revenue decline and margin compression
“gross margin was 20.4% for the first quarter of fiscal 2027, a decline of 400 basis points against the prior-year period.” · word for word
GIS segment deterioration
“GIS organic revenue growth (11.1) %” · word for word
Restructuring execution risk
“Total restructuring costs recorded, net of reversals, was $26 million for the first quarter of fiscal 2027” · word for word
30 Jul 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Leadership transition may cause short-term uncertainty.
“Resignation of a key executive; new appointment may take time to integrate.”
30 Jul 20268-K · 2.02DXC Technology reported Q1 FY27 revenue of $3.00B (down 5.1% YoY), adjusted EBIT margin 5.0%, non-GAAP EPS $0.40 (down 41.2% YoY), bookings $3.0B (up 5% YoY), free cash flow $314M (up from $97M). Maintained full-year guidance.earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q1-2027 | $3.00B | -5% y/y |
| Organic revenue growth · Q1-2027 | -6.7% | |
| EBIT · Q1-2027 | $207M | +176% y/y |
| Adjusted EBIT · Q1-2027 | $150M | -31% y/y |
| Adjusted EBIT margin · Q1-2027 | 5.0% | |
| Non-GAAP diluted EPS · Q1-2027 | $0.40 | -41% y/y |
| Diluted EPS · Q1-2027 | $0.73 | |
| Free cash flow · Q1-2027 | $314M | +224% y/y |
| Cash from operations · Q1-2027 | $418M | +125% y/y |
| Bookings · Q1-2027 | $3.00B | +5% y/y |
Guidance
FY27 revenue $12.10-12.35B (organic decline 5.0-3.0% YoY); adjusted EBIT margin 6.0-7.0%; non-GAAP diluted EPS $2.40-2.90; free cash flow ~$685M (raised from ~$600M). Q2 FY27 revenue $2.97-3.00B (organic decline 6.5-5.5% YoY); adjusted EBIT margin ~6.0%; non-GAAP diluted EPS ~$0.55.
Maintained full-year guidance with slight FCF raise due to litigation proceeds; Q2 guidance implies continued revenue decline
Risks flagged
Revenue decline continues, especially in GIS segment
“Total revenue down 5.1% YoY; GIS revenue down 9.4% YoY”
Adjusted EBIT margin compression
“Adjusted EBIT margin 5.0% vs prior year 6.8% (implied)”
Non-GAAP EPS decline of 41.2% YoY
“Non-GAAP diluted EPS $0.40 vs $0.68 prior year”
4 Jun 2026DEF 14ADXC filed its 2026 proxy statement, disclosing executive compensation details, pay-for-performance alignment, and proposals to increase equity plan share reserves.open
Figures in the filing · each found in the filing text
| Revenue · FY2026 | $12.64B | -2% y/y |
| Net Income · FY2026 | $28M | |
| Cash Flow from Operations · FY2026 | $1.25B | |
| Free Cash Flow · FY2026 | $713M | |
| Adjusted EBIT · FY2026 | $970M | |
| Adjusted EBIT Margin · FY2026 | 7.7% | |
| Organic Revenue Growth · FY2026 | -4.8% | |
| Annual Incentive Payout · FY2026 | 77.0% | |
| CEO Target Total Direct Compensation · FY2026 | $20M | |
| CEO Front-Loaded Equity Grant Value · FY2026 | $45M |
Risks flagged
Revenue Decline and Organic Revenue Contraction
“Revenue of $12,644 million, Revenue Growth of -1.8% and Organic Revenue Growth* of -4.8%” · word for word
Low Net Income and Margin Pressure
“Net income of $28 million and net income margin of 0.2%” · word for word
Stock Price Decline and TSR Underperformance
“DXC’s three-year TSR performance of -50.88% was compared against the custom group of peers and calculated to be at the 6th percentile of the rTSR peer group” · word for word
Macroeconomic and Geopolitical Uncertainty
“During fiscal 2026, DXC encountered various challenges, including macroeconomic uncertainty and geopolitical risks, affecting the markets where many of our customers operate.” · word for word
Sales Execution Challenges
“We also experienced some challenges closing select sales opportunities despite advancing to the final stages of competitive pursuits” · word for word
8 May 202610-KNet Income $28M (-93% y/y); Operating Cash Flow $1.25B (-11% y/y); Organic Revenue Growth -4.8open
Figures in the filing · each found in the filing text
| Net Income · FY2026 | $28M | -93% y/y |
| Operating Cash Flow · FY2026 | $1.25B | -11% y/y |
| Organic Revenue Growth · FY2026 | -4.8% | |
| Adjusted EBIT · FY2026 | $970M | -5% y/y |
| Total Debt · FY2026 | $3.55B | -8% y/y |
| CES Organic Revenue Growth · CES · FY2026 | -3.8% | |
| GIS Organic Revenue Growth · GIS · FY2026 | -7.2% | |
| Insurance Organic Revenue Growth · Insurance · FY2026 | 3.6% | |
| Cash Conversion Cycle · FY2026 | $22.00 |
Risks flagged
Debt and Credit Rating Risk
“We have indebtedness totaling approximately $3.6 billion as of March 31, 2026.” · word for word
Regulatory Compliance Cost
“We are subject to the General Data Protection Regulation (“GDPR”), among other regulations, imposing comprehensive data privacy compliance obligations” · word for word
AI Regulation Risk
“Certain AI-related regulations, such as the EU AI Act, could impose obligations on our business that may require us to change our products or business practices to comply.” · word for word
7 May 20268-K · 2.02Total Revenue $3,130.00 (-1% y/y); Adjusted EBIT $237M (+3% y/y); Free Cash Flow $110M (-1% y/y); Guidance: Q1 FY2027 revenue $2.97B-$3.00B, decline of 7.5%earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q4-2026 | $3130.00 | -1% y/y |
| Adjusted EBIT · Q4-2026 | $237M | +3% y/y |
| Free Cash Flow · Q4-2026 | $110M | -1% y/y |
| Bookings · Q4-2026 | $3300.00 | -14% y/y |
| Non-GAAP diluted EPS · Q4-2026 | $0.77 | -8% y/y |
| CES Revenue · Consulting and Engineering Services · Q4-2026 | $1.26B | +2% y/y |
| GIS Revenue · Global Infrastructure Services · Q4-2026 | $1.55B | -5% y/y |
| Insurance Revenue · Insurance Software & Services · Q4-2026 | $325M | +7% y/y |
Guidance
Q1 FY2027 revenue $2.97B-$3.00B, decline of 7.5%
Q1 FY2027 guidance implies continued revenue decline; adjusted EBIT margin ahead of expectations but top line weak.
Risks flagged
Organic revenue decline of 6.6% in Q4, with GIS segment particularly weak (-10.6% organic). Bookings down 13.5%.
“Total revenue for Q4 FY26 of $3.13 billion, down 1.2% YoY, down 6.6% on an organic basis... Bookings of $3.3 billion declined 13.5% year-over-year” · word for word
30 Jan 202610-QDXC reported Q3 fiscal 2026 results with organic revenue decline of 4.3%, but EPS improved due to cost cuts and buybacks.earningsopen
Figures in the filing · each found in the filing text
| Net income attributable to DXC common stockholders · Q3-2026 | $107M | +88% y/y |
| Adjusted EBIT · Q3-2026 | $263M | -8% y/y |
| Non-GAAP EPS · Q3-2026 | $0.96 | +4% y/y |
| Organic revenue growth · Q3-2026 | -4.3% | |
| Gross margin · Q3-2026 | 23.8% | |
| Operating cash flow · 9M-2026 | $1.01B | -7% y/y |
| Free cash flow · 9M-2026 | $644M | |
| Total debt · 2026-01-30 | $3.62B | -7% y/y |
| CES organic revenue growth · CES · Q3-2026 | -3.6% | |
| GIS organic revenue growth · GIS · Q3-2026 | -6.2% |
Risks flagged
Sustained organic revenue decline
“Organic revenue growth (4.3) % (4.2) % (4.3) % (4.7) %” · word for word
Gross margin contraction
“Gross margin ... a decrease of 1.3%”
High effective tax rate
“Our effective tax rate (“ETR”) was 35.7% and 51.9% for the three months ended December 31, 2025, and December 31, 2024, respectively, and 54.5% and 54.5% for the nine months ended December 31, 2025, and December 31, 2024, respectively.” · word for word
29 Jan 20268-K · 2.02Total revenue $3.19B (-1% y/y); Bookings $3.60B (-17% y/y); EBIT $179M (+23% y/y); Guidance: FY26 revenue ~$12.69B (decline ~4.3% organic) vs prior $12.67B-$12.81B (decline 4.5%-3.5%)earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q3-2026 | $3.19B | -1% y/y |
| Bookings · Q3-2026 | $3.60B | -17% y/y |
| EBIT · Q3-2026 | $179M | +23% y/y |
| Adjusted EBIT · Q3-2026 | $263M | -8% y/y |
| Diluted EPS · Q3-2026 | $0.61 | +97% y/y |
| Non-GAAP diluted EPS · Q3-2026 | $0.96 | +4% y/y |
| Free cash flow · Q3-2026 | $266M | -45% y/y |
| Cash generated from operations · Q3-2026 | $414M | -36% y/y |
Guidance
FY26 revenue ~$12.69B (decline ~4.3% organic) vs prior $12.67B-$12.81B (decline 4.5%-3.5%)
Full year revenue guidance narrowed to lower end; organic revenue decline expected to be ~4.3%; adjusted EBIT margin guidance improved to ~7.5% from prior 7.0%-8.0%.
Risks flagged
Revenue decline and bookings weakness indicate demand headwinds; organic revenue decline accelerating.
“Total revenue down 1% YoY; organic revenue down 4.3%; bookings down 17% YoY; FY26 revenue guidance narrowed to ~$12.69B (decline ~4.3% organic).”
GIS segment bookings down 26% YoY; trailing twelve month book to bill 0.99x.
“GIS bookings declined 26% YoY; trailing twelve month book to bill ratio of 0.99x.”
9 Dec 20258-K · 7.01, 8.01Net proceeds from 2030 notes 632,400,000open
Figures in the filing · each found in the filing text
| Net proceeds from 2030 notes · Q4-2025 | $632M |
Risks flagged
Higher interest cost on new notes (4.25% vs 1.75%/1.80%); increased leverage from new issuance.
“New notes bear 4.25% interest vs redeemed notes at 1.75% and 1.80%.”
2 Dec 20258-K · 8.01Aggregate principal amount of Senior Notes 650,000,000,000,000open
Figures in the filing · each found in the filing text
| Aggregate principal amount of Senior Notes · Q4-2025 | $650000.00B |
Risks flagged
Increased debt load may pressure future cash flows and interest coverage.
“€650M in new debt at 4.250% interest, adding to existing obligations.”
31 Oct 202510-QRevenue and earnings declined YoY; organic revenue contraction continues; cash flow improvedearningsopen
Figures in the filing · each found in the filing text
| Adjusted EBIT · Q2-2026 | $254M | -9% y/y |
| Net income attributable to DXC common stockholders · Q2-2026 | $36M | -14% y/y |
| Non-GAAP net income attributable to DXC common stockholders · Q2-2026 | $150M | -12% y/y |
| Diluted EPS · Q2-2026 | $0.20 | -13% y/y |
| Non-GAAP diluted EPS · Q2-2026 | $0.84 | -10% y/y |
| Free cash flow · 6M-2026 | $373M | |
| Total debt · Q2-2026 | $3.98B |
Risks flagged
Revenue decline persistence
“Organic revenue growth (4.2)% for Q2 2026”
Restructuring execution risk
“Restructuring costs $35 million for Q2 2026”
High effective tax rate
“Effective Tax Rate 69.5% for Q2 2026”
GIS segment decline
“GIS organic revenue growth (6.3)% for Q2 2026” · word for word
30 Oct 20258-K · 2.02Total revenue $3.16B (-2% y/y); Bookings $2.70B (+2% y/y); Adjusted EBIT margin 8; Guidance: FY2026 revenue $12.67B-$12.81B, organic decline 4.5%-3.5%earningsopen
Figures in the filing · each found in the filing text
| Total revenue · Q2-2026 | $3.16B | -3% y/y |
| Bookings · Q2-2026 | $2.70B | +2% y/y |
| Adjusted EBIT margin · Q2-2026 | 8.0% | |
| Non-GAAP diluted EPS · Q2-2026 | $0.84 | -10% y/y |
| Free cash flow · Q2-2026 | $240M | +400% y/y |
| CES revenue · Consulting and Engineering Services · Q2-2026 | $1.25B | -2% y/y |
| GIS revenue · Global Infrastructure Services · Q2-2026 | $1.59B | -4% y/y |
| Insurance revenue · Insurance Services · Q2-2026 | $320M | +5% y/y |
Guidance
FY2026 revenue $12.67B-$12.81B, organic decline 4.5%-3.5%
FY2026 guidance narrowed with organic revenue decline of 4.5%-3.5%, adjusted EBIT margin 7.0%-8.0%, free cash flow ~$650M.
Risks flagged
Revenue decline persists across core segments, especially GIS organic -6.3%.
“GIS revenue down 4.2% YoY (down 6.3% on an organic basis)”
Guidance implies continued organic revenue decline of 4.5%-3.5% for FY2026.
“FY2026 organic revenue decline guidance of 4.5% to 3.5%”
DXC Technology Company — questions
- What did DXC Technology Company file recently?
- 13 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-31 — DXC reported Q1 FY2027 results with revenue decline and margin compression, but a large litigation gain boosted EPS.
Every figure on this page comes from DXC Technology Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.